High Court gives go-ahead for UK puberty blocker trial to continue

Regulatoryapprovedpuberty blockerPositive

AI Analysis

The UK High Court has approved the continuation of the PATHWAYS puberty blocker trial after protocol amendments following a pause in February 2026.

High Court approved continuation of PATHWAYS trial after protocol amendments

Importance:5/10

Sentiment:

0.60

puberty blockersclinical trialregulatory approvalUKPATHWAYS trial

Read the original article

Published by Clinical Trials Arena on August 3, 2026 3:44 PM